British Lung Foundation   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (1984)

Organization Overview

First Clinical Trial
2001
NCT00440687
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

British Lung Foundation